Remimazolam is an ultra short-acting benzodiazepine used for the induction and maintenence of procedural sedation during short procedures. Reference standards of Remimazolam API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Remimazolam
Catalogue No.:PA 18 1480000
CAS :
Molecular Formula : C21H19BrN4O2
Molecular Weight : 439.31
Methyl 3-((3S)-7-bromo-2-((2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propanoate
Catalogue No.:PA 18 1481000
Molecular Formula : C21H23BrN4O3
Molecular Weight : 459.34
Methyl 3-((3S)-7-chloro-2-((2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propanoate
Catalogue No.:PA 18 1481001
Molecular Formula : C21H23ClN4O3
Molecular Weight : 414.89
Methyl 3-((S)-7-bromo-2-(((S)-2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propanoate
Catalogue No.:PA 18 1481002
Methyl 3-((S)-7-bromo-2-(((R)-2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propanoate
Catalogue No.:PA 18 1481003
Methyl 3-((R)-7-bromo-2-(((R)-2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propanoate
Catalogue No.:PA 18 1481004
Methyl 3-((R)-7-bromo-2-(((S)-2-hydroxypropyl)amino)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propanoate
Catalogue No.:PA 18 1481005
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
